𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus

✍ Scribed by Frédéric Lajaunias; Akinori Ida; Shuichi Kikuchi; Liliane Fossati-Jimack; Eduardo Martinez-Soria; Thomas Moll; Che-Leung Law; Shozo Izui


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
151 KB
Volume
48
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objective

CD22, a B cell–restricted transmembrane glycoprotein, regulates B cell antigen receptor signaling upon interaction with α2,6‐linked sialic acid–bearing glycans, which act as ligands and are expressed on B and T cells. In this study, we investigated how the expression of CD22 ligand (CD22L) is modulated following lymphocyte activation or during the course of systemic lupus erythematosus (SLE).

Methods

The expression levels of CD22L on B and T cells in nonautoimmune mice were assessed by flow cytometric analysis using a soluble recombinant form of CD22, following stimulation with antigen or mitogen in vitro. In addition, the expression levels of CD22L on circulating lymphocytes were correlated with the progression of SLE in lupus‐prone mice.

Results

We observed a constitutive expression of CD22L on mature B cells, but not T cells, in nonautoimmune mice. However, CD22L levels were up‐regulated selectively on T cells (but not B cells) stimulated with antigens in vitro, while their expression levels on B cells was up‐modulated following polyclonal activation with lipopolysaccharide. Furthermore, expression of CD22L was increased on circulating B cells (and to a lesser extent on T cells) in parallel with progression of SLE in several different lupus‐prone mice and in a cohort of (C57BL/6 × [NZB × C57BL/6.Yaa]F~1~) backcross mice.

Conclusion

The expression of CD22L is differentially regulated in B and T cells, and high expression of CD22L on circulating B cells is a marker for development of severe SLE, suggesting a role for CD22–CD22L interactions in SLE as well as in the regulation of humoral immunity.


📜 SIMILAR VOLUMES


Differential expression of the B cell-re
✍ Dorothee Viemann; Peter Schlenke; Hans-Jörg Hammers; Holger Kirchner; Andrea Kru 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

Newborns respond poorly to certain antigens and produce mainly IgM antibodies. By flow cytometry we analyzed on neonatal and adult B cells the expression of CD22, a B cell receptor (BCR)-associated membrane molecule, known as negative modulator of BCR signaling. After T cell-independent (TI-)stimula

Reduced expression of decay-accelerating
✍ David M. Cauvi; Gabrielle Cauvi; K. Michael Pollard 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract ## Objective Deficiency of decay‐accelerating factor 1 (termed Daf1 in mice) has been shown to exacerbate autoimmunity, and recent studies have suggested that this may be explained by Daf1 acting as a regulator of T cell immunity. The aim of this study was to determine whether Daf1 exp